{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:30:16Z","timestamp":1793399416954,"version":"4.5.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T00:00:00Z","timestamp":1241654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T00:00:00Z","timestamp":1241654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/leu.2009.89","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T09:42:22Z","timestamp":1241689342000},"page":"1545-1556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":397,"title":["International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma"],"prefix":"10.1038","volume":"23","author":[{"given":"M","family":"Dimopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R L","family":"Comenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Beksac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lokhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S V","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Niesvizky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L A","family":"Moulopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B G M","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the IMWG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,7]]},"reference":[{"key":"BFleu200989_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","volume":"16","author":"E Terpos","year":"2005","unstructured":"Terpos E, Dimopoulos MA . Myeloma bone disease: pathophysiology and management. Ann Oncol 2005; 16: 1223\u20131231.","journal-title":"Ann Oncol"},{"key":"BFleu200989_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"BFleu200989_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0037-1963(01)90020-4","volume":"38","author":"NS Callander","year":"2001","unstructured":"Callander NS, Roodman GD . Myeloma bone disease. Semin Hematol 2001; 38: 276\u2013285.","journal-title":"Semin Hematol"},{"key":"BFleu200989_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11864-000-0017-x","volume":"1","author":"N Raje","year":"2000","unstructured":"Raje N, Anderson KC . Multiple myeloma. Curr Treat Options Oncol 2000; 1: 73\u201382.","journal-title":"Curr Treat Options Oncol"},{"key":"BFleu200989_CR5","first-page":"300","volume":"4","author":"J Epstein","year":"2006","unstructured":"Epstein J, Walker R . Myeloma and bone disease: \u201c\u2033the dangerous tango\u201d. Clin Adv Hematol Oncol 2006; 4: 300\u2013306.","journal-title":"Clin Adv Hematol Oncol"},{"key":"BFleu200989_CR6","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","volume":"108","author":"N Giuliani","year":"2006","unstructured":"Giuliani N, Rizzoli V, Roodman GD . Multiple myeloma bone disease: pathophysiology of osteoblast inhibition. Blood 2006; 108: 3992\u20133996.","journal-title":"Blood"},{"key":"BFleu200989_CR7","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1182\/blood-2007-03-067710","volume":"110","author":"E Terpos","year":"2007","unstructured":"Terpos E, Sezer O, Croucher P, Dimopoulos MA . Myeloma bone disease and proteasome inhibition therapies. Blood 2007; 110: 1098\u20131104.","journal-title":"Blood"},{"key":"BFleu200989_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.0954-6820.1982.tb03234.x","volume":"212","author":"A Wahlin","year":"1982","unstructured":"Wahlin A, Holm J, Osterman G, Norberg B . Evaluation of serial bone X-ray examination in multiple myeloma. Acta Med Scand 1982; 212: 385\u2013387.","journal-title":"Acta Med Scand"},{"key":"BFleu200989_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.0902-4441.2004.00177.x","volume":"72","author":"L Mileshkin","year":"2004","unstructured":"Mileshkin L, Blum R, Seymour JF, Patrikeos A, Hicks RJ, Prince HM . A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma. Eur J Haematol 2004; 72: 32\u201337.","journal-title":"Eur J Haematol"},{"key":"BFleu200989_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00256-006-0184-3","volume":"36","author":"ME Mulligan","year":"2007","unstructured":"Mulligan ME, Badros AZ . PET\/CT and MR imaging in myeloma. Skeletal Radiol 2007; 36: 5\u201316.","journal-title":"Skeletal Radiol"},{"key":"BFleu200989_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0009-9260(67)80010-2","volume":"18","author":"GA Edelstyn","year":"1967","unstructured":"Edelstyn GA, Gillespie PJ, Grebbell FS . The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol 1967; 18: 158\u2013162.","journal-title":"Clin Radiol"},{"key":"BFleu200989_CR12","first-page":"567","volume":"89","author":"N Abildgaard","year":"2004","unstructured":"Abildgaard N, Brixen K, Eriksen EF, Kristensen JE, Nielsen JL, Heickendorff L . Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma. Haematologica 2004; 89: 567\u2013577.","journal-title":"Haematologica"},{"key":"BFleu200989_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0950-3536(05)80255-0","volume":"8","author":"M Boccadoro","year":"1995","unstructured":"Boccadoro M, Pileri A . Plasma cell dyscrasias: classification, clinical and laboratory characteristics, and differential diagnosis. Baillieres Clin Haematol 1995; 8: 705\u2013719.","journal-title":"Baillieres Clin Haematol"},{"key":"BFleu200989_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/02841859709171259","volume":"38","author":"B Agren","year":"1997","unstructured":"Agren B, L\u00f6nnqvist B, Bj\u00f6rkstrand B, Rudberg U, Aspelin P . Radiography and bone scintigraphy in bone marrow transplant multiple myeloma patients. Acta Radiol 1997; 38: 144\u2013150.","journal-title":"Acta Radiol"},{"key":"BFleu200989_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/00005792-198009000-00005","volume":"59","author":"SB Kapadia","year":"1980","unstructured":"Kapadia SB . Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine 1980; 59: 380\u2013392.","journal-title":"Medicine"},{"key":"BFleu200989_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.clinimag.2007.04.005","volume":"31","author":"M Chassang","year":"2007","unstructured":"Chassang M, Grimaud A, Cucchi JM, Novellas S, Amoretti N, Chevallier P et al. Can low-dose computed tomographic scan of the spine replace conventional radiography? An evaluation based on imaging myelomas, bone metastases, and fractures from osteoporosis. Clin Imaging 2007; 31: 225\u2013227.","journal-title":"Clin Imaging"},{"key":"BFleu200989_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE . A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1975; 36: 842\u2013854.","journal-title":"Cancer"},{"issue":"Spec No A","key":"BFleu200989_CR18","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1102\/1470-7330.2004.0010","volume":"4","author":"CD Collins","year":"2004","unstructured":"Collins CD . Multiple myeloma. Cancer Imaging 2004; 4 (Spec No A): S47\u2013S53.","journal-title":"Cancer Imaging"},{"key":"BFleu200989_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0002-9343(93)90120-E","volume":"94","author":"MA Dimopoulos","year":"1993","unstructured":"Dimopoulos MA, Moulopoulos A, Smith T, Delasalle KB, Alexanian R . Risk of disease progression in asymptomatic multiple myeloma. Am J Med 1993; 94: 57\u201361.","journal-title":"Am J Med"},{"key":"BFleu200989_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-0609.1991.tb01857.x","volume":"47","author":"F Wisl\u00f8ff","year":"1991","unstructured":"Wisl\u00f8ff F, Andersen P, Andersson TR, Brandt E, Eika C, Fjaestad K et al. Incidence and follow-up of asymptomatic multiple myeloma. The myeloma project of health region I in Norway. II. Eur J Haematol 1991; 47: 338\u2013341.","journal-title":"Eur J Haematol"},{"key":"BFleu200989_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: 749\u2013757.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2141.2007.06536.x","volume":"137","author":"J Singh","year":"2007","unstructured":"Singh J, Fairbairn KJ, Williams C, Das-Gupta EP, Russell NH, Byrne JL . Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi-disciplinary teams in the accurate staging and treatment of myeloma patients. Br J Haematol 2007; 137: 172\u2013173.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR23","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1080\/07357900801965059","volume":"26","author":"M Mulligan","year":"2008","unstructured":"Mulligan M, Smith S, Talmi D . Whole body radiography for bone survey screening of cancer and myeloma patients. Cancer Invest 2008; 26: 916\u2013922.","journal-title":"Cancer Invest"},{"issue":"Spec No A","key":"BFleu200989_CR24","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1102\/1470-7330.2005.0033","volume":"5","author":"CD Collins","year":"2005","unstructured":"Collins CD . Problems monitoring response in multiple myeloma. Cancer Imaging 2005; 5 (Spec No A): S119\u2013S126.","journal-title":"Cancer Imaging"},{"key":"BFleu200989_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/01.ta.0000226154.38852.e6","volume":"61","author":"JL Antevil","year":"2006","unstructured":"Antevil JL, Sise MJ, Sack DI, Kidder B, Hopper A, Brown CV . Spiral computed tomography for the initial evaluation of spine trauma: a new standard of care? J Trauma 2006; 61: 382\u2013387.","journal-title":"J Trauma"},{"key":"BFleu200989_CR26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/000313480607201025","volume":"72","author":"AK Obaid","year":"2006","unstructured":"Obaid AK, Barleben A, Portal D, Lush S, Cinat M . Utility of plain film pelvic radiographs in blunt trauma patients in the emergency department. Am Surg 2006; 72: 951\u2013954.","journal-title":"Am Surg"},{"key":"BFleu200989_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-0609.1985.tb00797.x","volume":"35","author":"RA Kyle","year":"1985","unstructured":"Kyle RA . Multiple myeloma: current therapy and a glimpse of the future. Scand J Haematol 1985; 35: 38\u201347.","journal-title":"Scand J Haematol"},{"key":"BFleu200989_CR28","first-page":"429","volume":"100","author":"PN Scutellari","year":"2000","unstructured":"Scutellari PN, Addonisio G, Righi R, Giganti M . Diagnostic imaging of bone metastases. Radiol Med 2000; 100: 429\u2013435.","journal-title":"Radiol Med"},{"key":"BFleu200989_CR29","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","volume":"180","author":"AH Mahnken","year":"2002","unstructured":"Mahnken AH, Wildberger JE, Gehbauer G, Schmitz-Rode T, Blaum M, Fabry U et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol 2002; 180: 1429\u20131436.","journal-title":"AJR Am J Roentgenol"},{"key":"BFleu200989_CR30","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/cncr.22572","volume":"109","author":"M Horger","year":"2007","unstructured":"Horger M, Kanz L, Denecke B, Vonthein R, Pereira P, Claussen CD et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer 2007; 109: 1617\u20131626.","journal-title":"Cancer"},{"key":"BFleu200989_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejrad.2004.04.015","volume":"54","author":"M Horger","year":"2005","unstructured":"Horger M, Claussen CD, Bross-Bach U, Vonthein R, Trabold T, Heuschmid M et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol 2005; 54: 289\u2013297.","journal-title":"Eur J Radiol"},{"key":"BFleu200989_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1148\/radiol.2372041741","volume":"237","author":"CD Furtado","year":"2005","unstructured":"Furtado CD, Aguirre DA, Sirlin CB, Dang D, Stamato SK, Lee P et al. Whole-body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology 2005; 237: 385\u2013394.","journal-title":"Radiology"},{"key":"BFleu200989_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.rct.0000237820.41549.c9","volume":"31","author":"J Hur","year":"2007","unstructured":"Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS . Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. J Comput Assist Tomogr 2007; 31: 342\u2013347.","journal-title":"J Comput Assist Tomogr"},{"key":"BFleu200989_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.clinimag.2007.04.005","volume":"31","author":"M Chassang","year":"2007","unstructured":"Chassang M, Grimaud A, Cucchi JM, Novellas S, Amoretti N, Chevallier P et al. Can low-dose computed tomographic scan of the spine replace conventional radiography? An evaluation based on imaging myelomas, bone metastases, and fractures from osteoporosis. Clin Imaging 2007; 31: 225\u2013227.","journal-title":"Clin Imaging"},{"key":"BFleu200989_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejrad.2005.01.017","volume":"55","author":"A Baur-Melnyk","year":"2005","unstructured":"Baur-Melnyk A, Buhmann S, Durr HR, Reiser M . Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 2005; 55: 56\u201363.","journal-title":"Eur J Radiol"},{"key":"BFleu200989_CR36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","volume":"178","author":"AH Mahnken","year":"2002","unstructured":"Mahnken AH, Wildberger JE, Gehbauer G, Schmitz-Rode T, Blaum M, Fabry U et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol 2002; 178: 1429\u20131436.","journal-title":"AJR Am J Roentgenol"},{"key":"BFleu200989_CR37","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/S0140-6736(88)91973-3","volume":"1","author":"J Joffe","year":"1988","unstructured":"Joffe J, Williams MP, Cherryman GR, Gore M, McElwain TJ, Selby P . Magnetic resonance imaging in myeloma. Lancet 1988; 1: 1162\u20131163.","journal-title":"Lancet"},{"key":"BFleu200989_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1148\/radiology.204.1.9205247","volume":"204","author":"FE Lecouvet","year":"1997","unstructured":"Lecouvet FE, Malghem J, Michaux L, Michaux JL, Lehmann F, Maldague BE et al. Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow. Radiology 1997; 204: 201\u2013205.","journal-title":"Radiology"},{"key":"BFleu200989_CR39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00004728-199805000-00016","volume":"22","author":"FE Lecouvet","year":"1998","unstructured":"Lecouvet FE, Vande Berg BC, Michaux L, Jamart J, Maldague BE, Malghem J . Development of vertebral fractures in patients with multiple myeloma: does MRI enable recognition of vertebrae that will collapse? J Comput Assist Tomogr 1998; 22: 430\u2013436.","journal-title":"J Comput Assist Tomogr"},{"key":"BFleu200989_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1440-1673.1997.tb00460.x","volume":"41","author":"WF Van Gelderen","year":"1997","unstructured":"Van Gelderen WF, al-Hindawi M, Gale RS, Steward AH, Archibald CG . Significance of short tau inversion recovery magnetic resonance sequence in the management of skeletal injuries. Australas Radiol 1997; 41: 13\u201315.","journal-title":"Australas Radiol"},{"key":"BFleu200989_CR41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2141.2004.04809.x","volume":"124","author":"TH Diamond","year":"2004","unstructured":"Diamond TH, Hartwell T, Clarke W, Manoharan A . Percutaneous vertebroplasty for acute vertebral body fracture and deformity in multiple myeloma: a short report. Br J Haematol 2004; 124: 485\u2013487.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1148\/radiology.187.1.8451413","volume":"187","author":"P Lafforgue","year":"1993","unstructured":"Lafforgue P, Dahan E, Chagnaud C, Schiano A, Kasbarian M, Acquaviva PC . Early-stage avascular necrosis of the femoral head: MR imaging for prognosis in 31 cases with at least 2 years of follow-up. Radiology 1993; 187: 199\u2013204.","journal-title":"Radiology"},{"key":"BFleu200989_CR43","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.V90.6.2127","volume":"90","author":"LA Moulopoulos","year":"1997","unstructured":"Moulopoulos LA, Dimopoulos MA . Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood 1997; 90: 2127\u20132147.","journal-title":"Blood"},{"key":"BFleu200989_CR44","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1148\/radiology.182.3.1535904","volume":"182","author":"HI Libshitz","year":"1992","unstructured":"Libshitz HI, Malthouse SR, Cunningham D, MacVicar AD, Husband JE . Multiple myeloma: appearance at MR imaging. Radiology 1992; 182: 833\u2013837.","journal-title":"Radiology"},{"key":"BFleu200989_CR45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejrad.2007.10.025","volume":"69","author":"M Weininger","year":"2008","unstructured":"Weininger M, Lauterbach B, Knop S, Pabst T, Kenn W, Hahn D et al. Whole-body MRI of multiple myeloma: Comparison of different MRI sequences in assessment of different growth patterns. Eur J Radiol 2008; 69: 339\u2013345.","journal-title":"Eur J Radiol"},{"key":"BFleu200989_CR46","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/annonc\/mdi362","volume":"16","author":"LA Moulopoulos","year":"2005","unstructured":"Moulopoulos LA, Gika D, Anagnostopoulos A, Delasalle K, Weber D, Alexanian R et al. Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma. Ann Oncol 2005; 16: 1824\u20131828.","journal-title":"Ann Oncol"},{"key":"BFleu200989_CR47","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1148\/radiology.185.3.1438772","volume":"185","author":"LA Moulopoulos","year":"1992","unstructured":"Moulopoulos LA, Varma DG, Dimopoulos MA, Leeds NE, Kim EE, Johnston DA et al. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease. Radiology 1992; 185: 833\u2013840.","journal-title":"Radiology"},{"key":"BFleu200989_CR48","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2214\/ajr.167.4.8819407","volume":"167","author":"A Stabler","year":"1996","unstructured":"Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF . Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol 1996; 167: 1029\u20131036.","journal-title":"AJR Am J Roentgenol"},{"key":"BFleu200989_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/028418519503600102","volume":"36","author":"K Carlson","year":"1995","unstructured":"Carlson K, Astrom G, Nyman R, Ahlstrom H, Simonsson B . MR imaging of multiple myeloma in tumour mass measurement of diagnosis and during treatment. Acta Radiol 1995; 36: 9\u201314.","journal-title":"Acta Radiol"},{"key":"BFleu200989_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0899-7071(01)00263-7","volume":"25","author":"H Isoda","year":"2001","unstructured":"Isoda H, Kojima H, Shimizu K, Kurokawa H, Ikeda K, Sawada S et al. Multiple myeloma: short T2 on MR imaging. Clin Imaging 2001; 25: 141\u2013143.","journal-title":"Clin Imaging"},{"key":"BFleu200989_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s002560050360","volume":"27","author":"A Baur","year":"1998","unstructured":"Baur A, St\u00e4bler A, Lamerz R, Bartl R, Reiser M . Light chain deposition disease in multiple myeloma: MR imaging features correlated with histopathological findings. Skeletal Radiol 1998; 27: 173\u2013176.","journal-title":"Skeletal Radiol"},{"key":"BFleu200989_CR52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(87)92383-X","volume":"2","author":"H Ludwig","year":"1987","unstructured":"Ludwig H, Fr\u00fchwald F, Tscholakoff D, Rasoul S, Neuhold A, Fritz E . Magnetic resonance imaging of the spine in multiple myeloma. Lancet 1987; 2: 364\u2013366.","journal-title":"Lancet"},{"key":"BFleu200989_CR53","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00330-005-0055-7","volume":"16","author":"N Ghanem","year":"2006","unstructured":"Ghanem N, Lohrmann C, Engelhardt M, Pache G, Uhl M, Saueressig U et al. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 2006; 16: 1005\u20131014.","journal-title":"Eur Radiol"},{"key":"BFleu200989_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-2141.1999.01529.x","volume":"106","author":"FE Lecouvet","year":"1999","unstructured":"Lecouvet FE, Malghem J, Michaux L, Maldague B, Ferrant A, Michaux JL et al. Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol 1999; 106: 35\u201339.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR55","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1365-2141.1995.tb05363.x","volume":"91","author":"R Tertti","year":"1995","unstructured":"Tertti R, Alanen A, Remes K . The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine. Br J Haematol 1995; 91: 658\u2013660.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR56","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2214\/AJR.07.2635","volume":"190","author":"A Baur-Melnyk","year":"2008","unstructured":"Baur-Melnyk A, Buhmann S, Becker C, Schoenberg SO, Lang N, Bartl R et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol 2008; 190: 1097\u20131104.","journal-title":"AJR Am J Roentgenol"},{"key":"BFleu200989_CR57","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","volume":"25","author":"R Walker","year":"2007","unstructured":"Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy Jr JD et al. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol 2007; 25: 1121\u20131128.","journal-title":"J Clin Oncol"},{"key":"BFleu200989_CR58","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354: 1362\u20131369.","journal-title":"N Engl J Med"},{"key":"BFleu200989_CR59","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","volume":"134","author":"J Pepe","year":"2006","unstructured":"Pepe J, Petrucci MT, Nofroni I, Fassino V, Diacinti D, Romagnoli E et al. Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 2006; 134: 485\u2013490.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR60","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1097\/00007632-199711010-00017","volume":"22","author":"L Bella\u00efche","year":"1997","unstructured":"Bella\u00efche L, Laredo JD, Liot\u00e9 F, Koeger AC, Hamze B, Ziza JM et al. Magnetic resonance appearance of monoclonal gammopathies of unknown significance and multiple myeloma. The GRI Study Group. Spine 1997; 22: 2551\u20132557.","journal-title":"Spine"},{"key":"BFleu200989_CR61","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1148\/radiology.202.1.8988218","volume":"202","author":"BC Vande Berg","year":"1997","unstructured":"Vande Berg BC, Michaux L, Lecouvet FE, Labaisse M, Malghem J, Jamart J et al. Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 1997; 202: 247\u2013251.","journal-title":"Radiology"},{"key":"BFleu200989_CR62","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","volume":"96","author":"MA Dimopoulos","year":"2000","unstructured":"Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R . Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood 2000; 96: 2037\u20132044.","journal-title":"Blood"},{"key":"BFleu200989_CR63","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1200\/JCO.1993.11.7.1311","volume":"11","author":"LA Moulopoulos","year":"1993","unstructured":"Moulopoulos LA, Dimopoulos MA, Weber D, Fuller L, Libshitz HI, Alexanian R . Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol 1993; 11: 1311\u20131315.","journal-title":"J Clin Oncol"},{"key":"BFleu200989_CR64","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0360-3016(98)00186-2","volume":"41","author":"RH Liebross","year":"1998","unstructured":"Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R . Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys 1998; 41: 1063\u20131067.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFleu200989_CR65","first-page":"CD004023","volume":"1","author":"Y He","year":"2003","unstructured":"He Y, Wheatley K, Clark O, Glasmacher A, Ross H, Djulbegovic B . Early versus deferred treatment for early stage multiple myeloma. Cochrane Database Syst Rev 2003; 1: CD004023.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFleu200989_CR66","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1517\/14656566.6.7.1127","volume":"6","author":"E Terpos","year":"2005","unstructured":"Terpos E, Rahemtulla A, Dimopoulos MA . Current treatment options for myeloma. Expert Opin Pharmacother 2005; 6: 1127\u20131142.","journal-title":"Expert Opin Pharmacother"},{"key":"BFleu200989_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0002-9343(93)90120-E","volume":"94","author":"MA Dimopoulos","year":"1993","unstructured":"Dimopoulos MA, Moulopoulos A, Smith T, Delasalle KB, Alexanian R . Risk of disease progression in asymptomatic multiple myeloma. Am J Med 1993; 94: 57\u201361.","journal-title":"Am J Med"},{"key":"BFleu200989_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1200\/JCO.1995.13.1.251","volume":"13","author":"LA Moulopoulos","year":"1995","unstructured":"Moulopoulos LA, Dimopoulos MA, Smith TL, Weber DM, Delasalle KB, Libshitz HI et al. Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 1995; 13: 251\u2013256.","journal-title":"J Clin Oncol"},{"key":"BFleu200989_CR69","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1046\/j.1365-2141.1999.01244.x","volume":"104","author":"X Mariette","year":"1999","unstructured":"Mariette X, Zagdanski AM, Guermazi A, Bergot C, Arnould A, Frija J et al. Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol 1999; 104: 723\u2013729.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR70","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1046\/j.1365-2141.1997.1122939.x","volume":"97","author":"DM Weber","year":"1997","unstructured":"Weber DM, Dimopoulos MA, Moulopoulos LA, Delasalle KB, Smith T, Alexanian R . Prognostic features of asymptomatic multiple myeloma. Br J Haematol 1997; 97: 810\u2013814.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR71","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1148\/radiology.193.2.7972760","volume":"193","author":"LA Moulopoulos","year":"1994","unstructured":"Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI . Multiple myeloma: MR patterns of response to treatment. Radiology 1994; 193: 441\u2013446.","journal-title":"Radiology"},{"key":"BFleu200989_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-2001-12920","volume":"5","author":"FE Lecouvet","year":"2001","unstructured":"Lecouvet FE, Vande Berg BC, Malghem J, Maldague BE . Magnetic resonance and computed tomography imaging in multiple myeloma. Semin Musculoskelet Radiol 2001; 5: 43\u201355.","journal-title":"Semin Musculoskelet Radiol"},{"key":"BFleu200989_CR73","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2214\/ajr.160.5.8470574","volume":"160","author":"A Rahmouni","year":"1993","unstructured":"Rahmouni A, Divine M, Mathieu D, Golli M, Dao TH, Jazaerli N et al. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol 1993; 160: 1049\u20131052.","journal-title":"AJR Am J Roentgenol"},{"key":"BFleu200989_CR74","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2214\/ajr.176.1.1760091","volume":"176","author":"FE Lecouvet","year":"2001","unstructured":"Lecouvet FE, Dechambre S, Malghem J, Ferrant A, Vande Berg BC, Maldague B . Bone marrow transplantation in patients with multiple myeloma: prognostic significance of MR imaging. AJR Am J Roentgenol 2001; 176: 91\u201396.","journal-title":"AJR Am J Roentgenol"},{"key":"BFleu200989_CR75","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2214\/ajr.183.3.1830645","volume":"183","author":"RP Hartman","year":"2004","unstructured":"Hartman RP, Sundaram M, Okuno SH, Sim FH . Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings. AJR Am J Roentgenol 2004; 183: 645\u2013653.","journal-title":"AJR Am J Roentgenol"},{"key":"BFleu200989_CR76","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1148\/radiology.201.1.8816551","volume":"201","author":"BC Van de Berg","year":"1996","unstructured":"Van de Berg BC, Lecouvet FE, Michaux L, Labaisse M, Malghem J, Jamart J et al. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis. Radiology 1996; 201: 243\u2013246.","journal-title":"Radiology"},{"key":"BFleu200989_CR77","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1148\/radiology.209.3.9844655","volume":"209","author":"FE Lecouvet","year":"1998","unstructured":"Lecouvet FE, Vande Berg BC, Michaux L, Malghem J, Maldague BE, Jamart J et al. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 1998; 209: 653\u2013660.","journal-title":"Radiology"},{"key":"BFleu200989_CR78","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1148\/radiology.134.3.7355226","volume":"134","author":"JM Woolfenden","year":"1980","unstructured":"Woolfenden JM, Pitt MJ, Durie BG, Moon TE . Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology 1980; 134: 723\u2013728.","journal-title":"Radiology"},{"key":"BFleu200989_CR79","first-page":"739","volume":"55","author":"HW Wahner","year":"1980","unstructured":"Wahner HW, Kyle RA, Beabout JW . Scintigraphic evaluation of the skeleton in multiple myeloma. Mayo Clin Proc 1980; 55: 739\u2013746.","journal-title":"Mayo Clin Proc"},{"key":"BFleu200989_CR80","first-page":"136","volume":"70","author":"PN Scutellari","year":"1985","unstructured":"Scutellari PN, Spanedda R, Feggi LM, Cervi PM . The value and limitations of total body scan in the diagnosis of multiple myeloma: a comparison with conventional skeletal radiography. Haematologica 1985; 70: 136\u2013142.","journal-title":"Haematologica"},{"key":"BFleu200989_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/02841859709171259","volume":"38","author":"B Agren","year":"1997","unstructured":"Agren B, L\u00f6nnqvist B, Bj\u00f6rkstrand B, Rudberg U, Aspelin P . Radiography and bone scintigraphy in bone marrow transplant multiple myeloma patients. Acta Radiol 1997; 38: 144\u2013150.","journal-title":"Acta Radiol"},{"key":"BFleu200989_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/030089169608200103","volume":"82","author":"L Maffioli","year":"1996","unstructured":"Maffioli L, Steevens J, Pauwels E, Bombardieri E . Applications of 99mTc-sestaMIBI in oncology. Tumori 1996; 82: 12\u201329.","journal-title":"Tumori"},{"key":"BFleu200989_CR83","first-page":"78","volume":"86","author":"E Balleari","year":"2001","unstructured":"Balleari E, Villa G, Garre S, Ghirlanda P, Agnese G, Carletto M et al. Technetium-99m-sestaMIBI scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease. Haematologica 2001; 86: 78\u201384.","journal-title":"Haematologica"},{"key":"BFleu200989_CR84","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/bjc.1996.636","volume":"74","author":"EB Tiravola","year":"1996","unstructured":"Tiravola EB, Biassoni L, Britton KE, Kaleva N, Kouykin V, Malpas JS . The use of 99m-Tc-MIBI scanning in multiple myeloma. Br J Cancer 1996; 74: 1815\u20131820.","journal-title":"Br J Cancer"},{"key":"BFleu200989_CR85","first-page":"1001","volume":"37","author":"BK Adams","year":"1996","unstructured":"Adams BK, Fataar A, Nizami MA . Technetium-99m-sestaMIBI uptake in myeloma. J Nucl Med 1996; 37: 1001\u20131002.","journal-title":"J Nucl Med"},{"key":"BFleu200989_CR86","first-page":"1430","volume":"28","author":"R Fonti","year":"2001","unstructured":"Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L et al. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Eur J Nucl Med 2001; 28: 1430\u20131432.","journal-title":"Eur J Nucl Med"},{"key":"BFleu200989_CR87","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00277-002-0600-2","volume":"82","author":"I Ak","year":"2003","unstructured":"Ak I, Aslan V, VArdareli E, Gulbas Z . Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow: correlation with CD38\/CD138 expressing myeloma cells. Ann Hematol 2003; 82: 88\u201392.","journal-title":"Ann Hematol"},{"key":"BFleu200989_CR88","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/MNM.0b013e3282f5e5df","volume":"29","author":"L Giovanella","year":"2008","unstructured":"Giovanella L, Taborelli M, Ceriani L, Zucca E, Cavalli F, Delaloye AB . 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS. Nucl Med Commun 2008; 29: 535\u2013541.","journal-title":"Nucl Med Commun"},{"key":"BFleu200989_CR89","first-page":"355","volume":"24","author":"G Villa","year":"2005","unstructured":"Villa G, Balleari E, Carletto M, Grosso M, Clavio M, Piccardo A et al. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience. J Exp Clin Cancer Res 2005; 24: 355\u2013361.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFleu200989_CR90","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00006231-200305000-00009","volume":"24","author":"E Alper","year":"2003","unstructured":"Alper E, Gurel M, Evrensel T, Ozkocaman V, Akbunar T, Demiray M . 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy. Nucl Med Commun 2003; 24: 537\u2013542.","journal-title":"Nucl Med Commun"},{"key":"BFleu200989_CR91","first-page":"4737","volume":"25","author":"GU Hung","year":"2005","unstructured":"Hung GU, Tsai CC, Tsai SC, Lin WY . Comparison of Tc-99m sestamibi and F-18 FDG-PET in the assessment of multiple myeloma. Anticancer Res 2005; 25: 4737\u20134741.","journal-title":"Anticancer Res"},{"key":"BFleu200989_CR92","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2385-3-2","volume":"3","author":"S Mirzaei","year":"2003","unstructured":"Mirzaei S, Filipits M, Keck A, Bergmayer W, Knoll P, Koehn H et al. Comparison of Technetium-99m-MIBI imaging with MRI for detection of spine involvement in patients with multiple myeloma. BMC Nucl Med 2003; 3: 2.","journal-title":"BMC Nucl Med"},{"key":"BFleu200989_CR93","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1600-0609.2005.00580.x","volume":"76","author":"D Nandurkar","year":"2006","unstructured":"Nandurkar D, Kalff V, Turlakow A, Spencer A, Bailey MJ, Kelly MJ . Focal MIBI uptake is a better indicator of active myeloma than diffuse uptake. Eur J Haematol 2006; 76: 141\u2013146.","journal-title":"Eur J Haematol"},{"key":"BFleu200989_CR94","first-page":"177","volume":"9","author":"J Koutsikos","year":"2006","unstructured":"Koutsikos J, Grigoraki V, Athanasoulis T, Velidaki A, Mamoulakis C, Zomas A et al. Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System. Hell J Nucl Med 2006; 9: 177\u2013180.","journal-title":"Hell J Nucl Med"},{"key":"BFleu200989_CR95","first-page":"281","volume":"49","author":"L Pace","year":"2005","unstructured":"Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B et al. Washout of sestamibi in predicting response to chemotherapy in patients with multiple myeloma. Q J Nucl Med Mol Imaging 2005; 49: 281\u2013285.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"BFleu200989_CR96","first-page":"631","volume":"28","author":"T Athanasoulis","year":"2003","unstructured":"Athanasoulis T, Koutsikos J, Moulopoulos LA, Tsiouris S, Dimopoulos MA, Zerva C . Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy. Clin Nucl Med 2003; 28: 631\u2013635.","journal-title":"Clin Nucl Med"},{"key":"BFleu200989_CR97","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00277-007-0263-0","volume":"86","author":"L Catalano","year":"2007","unstructured":"Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C et al. Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. Ann Hematol 2007; 86: 415\u2013423.","journal-title":"Ann Hematol"},{"key":"BFleu200989_CR98","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2214\/ajr.184.4.01841199","volume":"184","author":"MA Bredella","year":"2005","unstructured":"Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R . Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol 2005; 184: 1199\u20131204.","journal-title":"AJR Am J Roentgenol"},{"key":"BFleu200989_CR99","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2141.2007.06491.x","volume":"137","author":"S D'Sa","year":"2007","unstructured":"D'Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M . Guidelines for the use of imaging in the management of myeloma. Br J Haematol 2007; 137: 49\u201363.","journal-title":"Br J Haematol"},{"key":"BFleu200989_CR100","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/jmri.20349","volume":"22","author":"S Nos\u00e0s-Garcia","year":"2005","unstructured":"Nos\u00e0s-Garcia S, Moehler T, Wasser K, Kiessling F, Bartl R, Zuna I et al. Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers. J Magn Reson Imaging 2005; 22: 154\u2013162.","journal-title":"J Magn Reson Imaging"},{"key":"BFleu200989_CR101","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1095-0397(99)00016-3","volume":"2","author":"SM Larson","year":"1999","unstructured":"Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET\/FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999; 2: 159\u2013171.","journal-title":"Clin Positron Imaging"},{"key":"BFleu200989_CR102","first-page":"1457","volume":"43","author":"BGM Durie","year":"2002","unstructured":"Durie BGM, Waxman AD, D'Agnolo A, Williams C . Whole-body F-FDG PET identifies high-risk myeloma. J Nucl Med 2002; 43: 1457\u20131463.","journal-title":"J Nucl Med"},{"key":"BFleu200989_CR103","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1200\/JCO.2007.14.5631","volume":"26","author":"BE Hillner","year":"2008","unstructured":"Hillner BE, Siegel BA, Liu D, Shields AF, Gareen IF, Hanna L et al. Impact of positron emission tomography\/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol 2008; 26: 2155\u20132161.","journal-title":"J Clin Oncol"},{"key":"BFleu200989_CR104","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1200\/JCO.2007.15.6935","volume":"26","author":"SM Larson","year":"2008","unstructured":"Larson SM . Practice-based evidence of the beneficial impact of positron emission tomography in clinical oncology. J Clin Oncol 2008; 26: 2083\u20132084.","journal-title":"J Clin Oncol"},{"key":"BFleu200989_CR105","unstructured":"http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/myeloma.pdf."},{"key":"BFleu200989_CR106","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1053\/j.semnuclmed.2007.07.002","volume":"37","author":"E Even-Sapir","year":"2007","unstructured":"Even-Sapir E, Mishani E, Flusser G, Metser U . 18F-Fluoride positron emission tomography and positron emission tomography\/computed tomography. Semin Nucl Med 2007; 37: 462\u2013469.","journal-title":"Semin Nucl Med"},{"key":"BFleu200989_CR107","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/108497803770418382","volume":"18","author":"H Schirrmeister","year":"2003","unstructured":"Schirrmeister H, Buck AK, Bergmann L, Reske SN, Bommer M . Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm 2003; 18: 841\u2013845.","journal-title":"Cancer Biother Radiopharm"},{"key":"BFleu200989_CR108","first-page":"513","volume":"22","author":"C Nanni","year":"2008","unstructured":"Nanni C, Rubello D, Zamagni E, Castellucci P, Ambrosini V, Montini G et al. 18F-FDG PET\/CT in myeloma with presumed solitary plasmocytoma of bone. In Vivo 2008; 22: 513\u2013517.","journal-title":"In Vivo"},{"key":"BFleu200989_CR109","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3324\/haematol.12654","volume":"93","author":"P-Y Salaun","year":"2008","unstructured":"Salaun P-Y, Gastinne T, Frampas E, Boddet-Milin C, Moreau P, Bodere-Kraeber F . FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma. Haematologica 2008; 93: 1269\u20131271.","journal-title":"Haematologica"},{"key":"BFleu200989_CR110","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3324\/haematol.10554","volume":"92","author":"E Zamagni","year":"2007","unstructured":"Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 2007; 92: 50\u201355.","journal-title":"Haematologica"},{"key":"BFleu200989_CR111","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2967\/jnumed.107.045641","volume":"49","author":"R Fonti","year":"2008","unstructured":"Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F et al. 18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. J Nucl Med 2008; 49: 195\u2013200.","journal-title":"J Nucl Med"},{"key":"BFleu200989_CR112","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/02841850801898625","volume":"49","author":"J Hur","year":"2008","unstructured":"Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS . Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma. Acta Radiol 2008; 49: 427\u2013435.","journal-title":"Acta Radiol"},{"key":"BFleu200989_CR113","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00259-005-0004-3","volume":"33","author":"C Nanni","year":"2006","unstructured":"Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D et al. Role of 18F-FDG PET\/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging 2006; 33: 525\u2013531.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFleu200989_CR114","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00256-006-0127-z","volume":"35","author":"RJ Breyer III","year":"2006","unstructured":"Breyer III RJ, Mulligan ME, Smith SE, Line BR, Badros AZ . Comparison of imaging with FDG PET\/CT with other imaging modalities in myeloma. Skeletal Radiol 2006; 35: 632\u2013640.","journal-title":"Skeletal Radiol"},{"key":"BFleu200989_CR115","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/01.mnm.0000171779.65284.eb","volume":"26","author":"L Gorospe","year":"2005","unstructured":"Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Herna Ndez S . Whole-body PET\/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun 2005; 26: 671\u2013687.","journal-title":"Nucl Med Commun"},{"key":"BFleu200989_CR116","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.semnuclmed.2003.12.003","volume":"34","author":"G Cook","year":"2004","unstructured":"Cook G, Wegner E, Fogelman I . Pitfalls and artifacts in 18FDG PET and PET\/CT oncologic imaging. Semin Nucl Med 2004; 34: 122\u2013133.","journal-title":"Semin Nucl Med"},{"issue":"Suppl 1","key":"BFleu200989_CR117","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1007\/s00256-006-0152-y","volume":"36","author":"K Strobel","year":"2007","unstructured":"Strobel K, Bode B, Lardinois D, Exner U . PET-positive fibrous dysplasia\u2013a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery. Skeletal Radiol 2007; 36 (Suppl 1): S24\u2013S28.","journal-title":"Skeletal Radiol"},{"key":"BFleu200989_CR118","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","volume":"24","author":"A Badros","year":"2006","unstructured":"Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006; 24: 945\u2013952.","journal-title":"J Clin Oncol"},{"key":"BFleu200989_CR119","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1200\/JCO.2005.11.676","volume":"23","author":"G Talamo","year":"2005","unstructured":"Talamo G, Angtuaco E, Walker RC, Dong L, Miceli MH, Zangari M et al. Avascular necrosis of femoral and\/or humeral heads in multiple myeloma. J Clin Oncol 2005; 23: 5217\u20135223.","journal-title":"J Clin Oncol"},{"key":"BFleu200989_CR120","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1148\/radiol.2422051980","volume":"242","author":"A Dankerl","year":"2007","unstructured":"Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D et al. Multiple myeloma: molecular imaging with 11C-methionine PET\/CT \u2013 initial experience. Radiology 2007; 242: 498\u2013508.","journal-title":"Radiology"},{"key":"BFleu200989_CR121","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.2967\/jnumed.108.056713","volume":"49","author":"BE Hillner","year":"2008","unstructured":"Hillner BE, Siegel BA, Shields AF, Liu D, Gareen IF, Hunt E et al. Relationship between cancer type and impact of PET and PET\/CT on intended management: findings of the National Oncologic PET Registry. J Nucl Med 2008; 49: 1928\u20131935.","journal-title":"J Nucl Med"},{"key":"BFleu200989_CR122","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF02352255","volume":"4","author":"MK Lewis","year":"1994","unstructured":"Lewis MK, Blake GM, Fogelman I . Patient dose in dual x-ray absorptiometry. Osteoporos Int 1994; 4: 11\u201315.","journal-title":"Osteoporos Int"},{"key":"BFleu200989_CR123","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bmj.307.6897.172","volume":"307","author":"T Masud","year":"1993","unstructured":"Masud T, Langley S, Wiltshire P, Doyle DV, Spector TD . Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 1993; 307: 172\u2013173.","journal-title":"BMJ"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200989","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:03:40Z","timestamp":1648735420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,7]]},"references-count":123,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BFleu200989"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.89","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,7]]},"assertion":[{"value":"2 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}